eNLife Research

India · Biotech

eNLife Research develops blood-based biomarker technology for earlier detection of Alzheimer’s and other neurodegenerative diseases.

Product

eNLife Research is developing diagnostic technology to help clinicians identify neurodegenerative disease before symptoms emerge. Its Alzheimer’s programme combines blood biomarkers with computational analysis and focuses on evidence relevant to Indian populations.

The research-stage assay examines a panel of five to seven biomarkers, including amyloid beta and abnormal tau proteins. Clinical validation is the next development step; the company’s ambition for earlier detection remains a research objective.

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Seed₹60MPiper Serica — Lead
Sourceseconomictimes.indiatimes.com ↗enlife.in ↗linkedin.com ↗